Company / Return on Equity (ROE)
Avanos Medical, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-9.4%
FY2025
5-year range
-47.3% / 3.9%
FY2021-FY2025
Trend
+80.2%
vs FY2024
Sector context
#104 of 147
Health Care
What the data says
Avanos Medical, Inc. reports negative total equity of -9.4% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-9.4% in FY2025 with a 5-year CAGR of -7.1%.
Declined from -5.0% to -9.4% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -13.3pp
- 5-Year Change
- -7.1pp
- 10-Year Change
- -
Sector benchmark
#104 of 147 in Health CareTop 71% of 147This company -9.4% Sector average -3.0%
▼
-208.0% below sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 80.2% year-over-year.
- Currently 6.3pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2017.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -9.4% | +80.2% |
| FY2024 | -47.3% | -846.6% |
| FY2023 | -5.0% | -227.9% |
| FY2022 | 3.9% | +682.0% |
| FY2021 | 0.5% | +121.7% |
| FY2020 | -2.3% | +36.3% |
| FY2019 | -3.6% | -181.5% |
| FY2018 | 4.4% | -32.1% |
| FY2017 | 6.5% | +80.6% |
| FY2016 | 3.6% | +108.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026